DRExplainer: Quantifiable interpretability in drug response prediction with directed graph convolutional network

IF 6.2 2区 医学 Q1 COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE Artificial Intelligence in Medicine Pub Date : 2025-03-04 DOI:10.1016/j.artmed.2025.103101
Haoyuan Shi , Tao Xu , Xiaodi Li , Qian Gao , Zhiwei Xiong , Junfeng Xia , Zhenyu Yue
{"title":"DRExplainer: Quantifiable interpretability in drug response prediction with directed graph convolutional network","authors":"Haoyuan Shi ,&nbsp;Tao Xu ,&nbsp;Xiaodi Li ,&nbsp;Qian Gao ,&nbsp;Zhiwei Xiong ,&nbsp;Junfeng Xia ,&nbsp;Zhenyu Yue","doi":"10.1016/j.artmed.2025.103101","DOIUrl":null,"url":null,"abstract":"<div><div>Predicting the response of a cancer cell line to a therapeutic drug is pivotal for personalized medicine. Despite numerous deep learning methods that have been developed for drug response prediction, integrating diverse information about biological entities and predicting the directional response remain major challenges. Here, we propose a novel interpretable predictive model, DRExplainer, which leverages a directed graph convolutional network to enhance the prediction in a directed bipartite network framework. DRExplainer constructs a directed bipartite network integrating multi-omics profiles of cell lines, the chemical structure of drugs and known drug response to achieve directed prediction. Then, DRExplainer identifies the most relevant subgraph to each prediction in this directed bipartite network by learning a mask, facilitating critical medical decision-making. Additionally, we introduce a quantifiable method for model interpretability that leverages a ground truth benchmark dataset curated from biological features. In computational experiments, DRExplainer outperforms state-of-the-art predictive methods and another graph-based explanation method under the same experimental setting. Finally, the case studies further validate the interpretability and the effectiveness of DRExplainer in predictive novel drug response. Our code is available at: <span><span>https://github.com/vshy-dream/DRExplainer</span><svg><path></path></svg></span>.</div></div>","PeriodicalId":55458,"journal":{"name":"Artificial Intelligence in Medicine","volume":"163 ","pages":"Article 103101"},"PeriodicalIF":6.2000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Artificial Intelligence in Medicine","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0933365725000363","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE","Score":null,"Total":0}
引用次数: 0

Abstract

Predicting the response of a cancer cell line to a therapeutic drug is pivotal for personalized medicine. Despite numerous deep learning methods that have been developed for drug response prediction, integrating diverse information about biological entities and predicting the directional response remain major challenges. Here, we propose a novel interpretable predictive model, DRExplainer, which leverages a directed graph convolutional network to enhance the prediction in a directed bipartite network framework. DRExplainer constructs a directed bipartite network integrating multi-omics profiles of cell lines, the chemical structure of drugs and known drug response to achieve directed prediction. Then, DRExplainer identifies the most relevant subgraph to each prediction in this directed bipartite network by learning a mask, facilitating critical medical decision-making. Additionally, we introduce a quantifiable method for model interpretability that leverages a ground truth benchmark dataset curated from biological features. In computational experiments, DRExplainer outperforms state-of-the-art predictive methods and another graph-based explanation method under the same experimental setting. Finally, the case studies further validate the interpretability and the effectiveness of DRExplainer in predictive novel drug response. Our code is available at: https://github.com/vshy-dream/DRExplainer.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用有向图卷积网络预测药物反应的可量化可解释性
预测癌细胞系对治疗药物的反应是个性化医疗的关键。尽管已经开发了许多用于药物反应预测的深度学习方法,但整合有关生物实体的各种信息并预测定向反应仍然是主要挑战。在这里,我们提出了一个新的可解释的预测模型,dreexplainer,它利用有向图卷积网络来增强有向二部网络框架中的预测。dreexplainer构建了一个定向双向网络,整合细胞系的多组学特征、药物的化学结构和已知的药物反应,实现定向预测。然后,dreexplainer通过学习掩码来识别该有向二部网络中每个预测的最相关子图,从而促进关键的医疗决策。此外,我们引入了一种可量化的模型可解释性方法,该方法利用了从生物特征中提取的真实基准数据集。在计算实验中,dreexplainer在相同的实验设置下优于最先进的预测方法和另一种基于图的解释方法。最后,案例研究进一步验证了dreexplorer在预测新药反应方面的可解释性和有效性。我们的代码可在:https://github.com/vshy-dream/DRExplainer。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Artificial Intelligence in Medicine
Artificial Intelligence in Medicine 工程技术-工程:生物医学
CiteScore
15.00
自引率
2.70%
发文量
143
审稿时长
6.3 months
期刊介绍: Artificial Intelligence in Medicine publishes original articles from a wide variety of interdisciplinary perspectives concerning the theory and practice of artificial intelligence (AI) in medicine, medically-oriented human biology, and health care. Artificial intelligence in medicine may be characterized as the scientific discipline pertaining to research studies, projects, and applications that aim at supporting decision-based medical tasks through knowledge- and/or data-intensive computer-based solutions that ultimately support and improve the performance of a human care provider.
期刊最新文献
UniStain: A unified and organ-aware virtual H&E staining framework for label-free autofluorescence images Clinical decision support system for detecting right ventricular dysfunction in acute pulmonary embolism: Explainable a new Binary Rule Search (BRS) ensembles and robustness evaluation Multi-scale feature enhancement in multi-task learning for medical image analysis Intelligent sentiment analysis with Arabic patient feedback on healthcare services in King Hussein Cancer Center Regret theory-based clinical efficacy evaluation method with three-way decision
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1